手機(jī)掃碼訪問(wèn)本站
微信咨詢
猜你喜歡
- 依托羥嗪
- ANATABINE
- 3-環(huán)戊基-1-丙醇
- 6-Chloro-nicotine
- 1133-80-8 / 2-溴芴的制備方法
- 2-BROMO-3-(3,5-DIFLUOROPHENYL)-1-PROPENE
- 5-Iodoresorcinol-2’,3’,4’-tri-O-acetyl-β-D-glucuronide Methyl Ester
- 443-48-1 / 甲硝唑的制備和臨床應(yīng)用研究
- N,N-二乙基哌啶-4-甲酰胺 HNO3 0.25H2O
- O-Des[2-aMinoethyl]-O-carboxyMethyl-dehydroaMlodipine
- 2-羥基-4-甲基嘧啶
- 3-甲基-2,4-二氧代-1,2,3,4-四氫喹唑啉-6-磺酰氯
- (7β,17β)-3-Methoxy-7-Methyl-estra-1,3,5(10)-trien-17-ol
- 2-丙烯酸十二烷基酯
- 2,4,6-三氟苯基異硫氰酸酯
- 3,5-二氟-4′-異丙基二苯甲酮
- 3-[[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]Methyl]-2,5-dihydro-2,2,5,5-tetraMethyl-1H-pyrrol-1-yloxy
- 2-哌嗪基-4-氨基-6,7-二甲氧基喹唑啉
- 拌種胺
- FMOC-3-EXO-AMINOBICYCLO[2.2.1]HEPT-5-ENE-2-EXO-CARBOXYLIC ACID
- ETHYL UREIDOACETATE
- 二苯基丙基磷
- 191217-81-9/抗帕金森藥物-普拉克索
- (S)-N4-芐基-2-異丙基哌嗪
- 2-氯煙酸乙酯
